The Surrogacy (Regulation) Act, 2021, says an insurance coverage of such amount and in such manner as may be prescribed in favour of the surrogate mother for a period of thirty-six months covering postpartum delivery complications from an insurance company or an agent recognised by the IRDAI
Hyderabad:
Regulator IRDAI has asked the insurers to provide relevant covers to surrogate mothers as specified in the two acts – Surrogacy Act, 2012 and ART Act, 2021.
“ All insurers are directed to comply with the provisions of the two Acts with immediate effect and ensure that suitable products are made available,’’ said IRDAI on Friday.
The Surrogacy (Regulation) Act, 2021, says an insurance coverage of such amount and in such manner as may be prescribed in favour of the surrogate mother for a period of thirty-six months covering postpartum delivery complications from an insurance company or an agent recognised by the IRDAI.
Surrogacy (Regulation) Rules, 2022 requires that the intending woman or couple purchase a general health insurance coverage in favour of surrogate mother for a period of thirty six months for an amount which is sufficient enough to cover all expenses for all complications arising out of pregnancy and also covering post- partum delivery complications.
Further the ART Act, 2021 outlines that an insurance coverage of such amount as may be prescribed for a period of twelve months in favour of the oocyte donor by the commissioning couple or woman from an insurance company.
The ART (Regulation) Rules,2022 says that the Intending couple or woman will purchase a general health insurance coverage in favor of oocyte donor for a period of 12 months for an amount which is sufficient enough to cover all expenses for all complications arising due to oocyte retrieval.
Amit Goel, director & principal pfficer Raghnall Insurance Broking & Risk Management, “As the insurance industry evolves to meet the changing needs of society, it is important for insurers to recognize the increasing demand for surrogacy and fertility treatments. The recent circular from IRDAI is a positive step towards providing comprehensive coverage for intending parents and surrogate mothers.
“We believe that this move will help promote the accessibility of surrogacy as a viable option for couples seeking to start a family, while also ensuring that all stakeholders are adequately covered.”